Document Type

Editorial

Department/Unit

School of Chinese Medicine

Language

English

Abstract

In continuation of the last year’s special issue “TCM Zheng Classification and Clinical Trials,” the time for 2014 issue has come. Now we are on the way from TCM Zheng classification in clinical trial to development of clinical practice guideline. Clinical effectiveness is what matters most in any treatment, including traditional Chinese medicine (TCM). Many clinical trials have been conducted in China to evaluate the effectiveness of TCM, but many of the studies are with poor quality and may be inaccessible to non-Chinese scientists. As shown in Figure 1, the number of randomized controlled trials (RCTs) for TCM is small in PubMed database. The situation may be partly due to the methodological difficulties, such as trial design and implementation of blinded trials of TCM Zheng classification (Bian Zheng, syndrome differentiation) treatments. These facts and figure illustrate that the present special issue focuses on an intractable topic in TCM research.

Publication Date

2015

Source Publication Title

Evidence-based Complementary and Alternative Medicine

Volume

2015

Start Page

538989

Publisher

Hindawi Publishing Corporation

Peer Reviewed

1

Copyright

Copyright © 2015 Aiping Lu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

DOI

10.1155/2015/538989

Link to Publisher's Edition

http://dx.doi.org/10.1155/2015/538989

ISSN (print)

1741427X

ISSN (electronic)

17414288

Share

COinS